Headshot photographs of the 12 Stanford Bio-X affiliated faculty who are collaborators on the projects.

January 26, 2023

12 Stanford Bio-X affiliated faculty members are among the 70 scientists from 29 institutions participating in 13 project teams to collaborate on basic research targeted at preparedness for future emerging pathogens that could threaten human health.

The Howard Hughes Medical Institute is committing $100 million to a new Emerging Pathogens Initiative to support basic research targeted at preparedness for emerging pathogens that could threaten human health in the future.

“We are optimistic that this initiative will help these scientists develop new, untested approaches that can reveal how pathogens work and how the human immune system responds to pathogen infection,” said HHMI Vice President and Chief Scientific Officer Leslie Vosshall. “With this program, we hope to gain some of the knowledge and tools we need to get a scientific head start on future epidemics.”

Stanford-Led Projects:

Focus area: Developing modular, multifunctional therapeutics from “parts lists” for a broad spectrum of RNA viruses


Lead Investigator:

Collaborators:


Focus area: Targeting cell envelope biosynthesis in Borrelia for diagnostics, therapeutics, and vaccine discovery


Lead Investigator:

Collaborators:

 

Focus area: Pathogenic brain states: cells and circuits involved in altered brain function after non-central nervous system infection


Lead Investigator:

Collaborators:

  • Akiko Iwasaki, HHMI, Yale University
  • Beth Stevens, HHMI, Boston Children’s Hospital
  • Karl Deisseroth, HHMI, Stanford University
  • Erin Gibson, Stanford University
  • Catherine Blish, Stanford University
  • Shane Liddelow, New York University
  • Ukpong Eyo, University of Virginia
     

READ MORE